Cargando…

Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically

BACKGROUND: Alzheimer's disease (AD) is a devastating neurodegenerative disorder that affects a large and growing number of elderly individuals. In addition to idiopathic disease, AD is also associated with autosomal dominant inheritance, which causes a familial form of AD (FAD). Some instances...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agca, Cansu, Fritz, Jason J, Walker, Lary C, Levey, Allan I, Chan, Anthony WS, Lah, James J, Agca, Yuksel
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268936/ https://www.ncbi.nlm.nih.gov/pubmed/18302776 http://dx.doi.org/10.1186/1471-2202-9-28

Ejemplares similares

Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention
por: Agca, Cansu, et al.
Publicado: (2016)

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease
por: Klakotskaia, Diana, et al.
Publicado: (2018)

Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP
por: Silverberg, Gerald D, et al.
Publicado: (2015)

APP21 transgenic rats develop age-dependent cognitive impairment and microglia accumulation within white matter tracts
por: Weishaupt, Nina, et al.
Publicado: (2018)

Hypertension and Pathogenic hAPP Independently Induce White Matter Astrocytosis and Cognitive Impairment in the Rat
por: Levit, Alexander, et al.
Publicado: (2020)

Post-thaw ATP supplementation enhances cryoprotective effect of iodixanol in rat spermatozoa
por: Kim, Suhee, et al.
Publicado: (2016)

Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey
por: Chan, Anthony W.S., et al.
Publicado: (2022)

White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer’s disease rat model
por: Ivanova, Nadezda, et al.
Publicado: (2020)

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
por: Steffen, Johannes, et al.
Publicado: (2017)

Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
por: Zhang, She-Qing, et al.
Publicado: (2013)

The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice
por: Rijal Upadhaya, Ajeet, et al.
Publicado: (2013)

Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype
por: Whitehouse, Isobel J., et al.
Publicado: (2016)

Expression of Pyruvate Carboxylase mRNA Variants in Liver of Dairy Cattle at Calving
por: Agca, Cansu, et al.
Publicado: (2007)

Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease
por: Zhang, Lan, et al.
Publicado: (2014)

A Transgenic Marker for Mouse B Lymphoid Precursors
por: Mårtensson, Inga-Lill, et al.
Publicado: (1997)

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
por: Dickey, Chad A, et al.
Publicado: (2005)

Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer’s disease lacking functional B and T cells
por: Späni, Claudia, et al.
Publicado: (2015)

Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-β Precursor Protein
por: Seita, Yasunari, et al.
Publicado: (2020)

Transgenic Expression of the Amyloid-β Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease–Like Traits In Vivo
por: Giliberto, Luca, et al.
Publicado: (2010)

Differential transgene expression patterns in Alzheimer mouse models revealed by novel human amyloid precursor protein‐specific antibodies
por: Höfling, Corinna, et al.
Publicado: (2016)

Venular amyloid accumulation in transgenic Fischer 344 Alzheimer’s disease rats
por: Bishay, J., et al.
Publicado: (2022)

Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice
por: Jung, Yu Yeon, et al.
Publicado: (2018)

Tau post-translational modifications in wildtype and human amyloid precursor protein transgenic mice
por: Morris, Meaghan, et al.
Publicado: (2015)

Hippocampal overexpression of Down syndrome cell adhesion molecule in amyloid precursor protein transgenic mice
por: Jia, Y.L., et al.
Publicado: (2017)

APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
por: Crews, Leslie, et al.
Publicado: (2009)

GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production
por: Herskowitz, Jeremy H., et al.
Publicado: (2012)

Expression of complement system components during aging and amyloid deposition in APP transgenic mice
por: Reichwald, Julia, et al.
Publicado: (2009)

Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice
por: Killick, Richard, et al.
Publicado: (2009)

Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice
por: Kukar, Thomas, et al.
Publicado: (2007)

Neuroprotective Effects of Asparagus officinalis Stem Extract in Transgenic Mice Overexpressing Amyloid Precursor Protein
por: Peng, Zhanglong, et al.
Publicado: (2021)

Production of transgenic first filial puppies expressing mutated human amyloid precursor protein gene
por: Hossein, Mohammad Shamim, et al.
Publicado: (2023)

Low-Dose Phosphodiesterase III Inhibitor Reduces the Vascular Amyloid Burden in Amyloid-β Protein Precursor Transgenic Mice
por: Yakushiji, Yusuke, et al.
Publicado: (2020)

The integration site of the APP transgene in the J20 mouse model of Alzheimer’s disease
por: Tosh, Justin L., et al.
Publicado: (2018)

The Alzheimer Amyloid Precursor Protein (APP) and Fe65, an APP-Binding Protein, Regulate Cell Movement
por: Sabo, Shasta L., et al.
Publicado: (2001)

Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer’s disease
por: Kukreja, Lokesh, et al.
Publicado: (2014)

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Iván, et al.
Publicado: (2013)

Immunocytochemical Characterization of Alzheimer’s Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Ivan, et al.
Publicado: (2014)

Cyclic Glycine-Proline Improves Memory and Reduces Amyloid Plaque Load in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease
por: Arora, Tushar, et al.
Publicado: (2023)

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010)

Phenotypic analysis of a transgenic Drosophila model of Alzheimer’s amyloid-β toxicity
por: Sekiya, Michiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lf1m18tqe32sfcmbbmk0konfbl